Skip to main content
Premium Trial:

Request an Annual Quote

Geisinger Approved for $1.4M to Study Sharing of Genomic Information with Patients

NEW YORK (GenomeWeb News) – Geisinger Health System's Genomic Medicine Institute announced on Friday approval of a $1.4 million research award from the Patient-Centered Outcomes Research Institute to study how best to share genomic results and information with patients.

The project will include scientists from Pennsylvania State University and Virginia Tech and will focus on optimal ways of sharing genomics results "to promote shared decision making." Marc Williams, director of the Genomic Medicine Institute, Geisinger's Sigfried and Janet Weis Center for Research, will lead the research.

As genomic information becomes more prevalent in the diagnosis and management of medical conditions, methods of sharing the information with patients is increasingly moving to the forefront, Geisinger said. The study being carried out will identify "how best to communicate genetic laboratory information, what part of the communication is of the greatest value to patients and clinicians, and how best to integrate the reporting into the day-to-day workflow at Geisinger in a way that is relevant and helpful," it added.

"We believe that a new type of genomic test report, tailored for patient as well as clinician use, promotes shared decision making and trust," Williams said in a statement. "It also allows patients to be more involved in the management of their disorders, better navigate the healthcare system, and make more informed decisions about their health and healthcare in conjunction with their clinicians."

The Patient-Centered Outcomes Research Institute is an independent, non-profit organization authorized by Congress in 2010 in order to fund research providing patients, their caregivers, and clinicians with evidence-based information that can be used for healthcare decisions.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.